CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer

Figure 2

The expression of CLDN4 in OC and the clinical importance of its presence has been investigated. (a) When compared with nontumor specimens, OC were found to have a significantly higher level of CLDN4 overexpression. (b) ROC assays were utilized in order to provide evidence that CLDN4 expression have diagnostic value. (c) The expression of CLDN4 in OC as determined by the GSE26712 datasets. (d) ROC assays based on the data found in GSE26712. (e–h) Association between CLDN4 expression and clinicopathological parameters, such as age, FIGO stage, lymphatic invasion, and histologic grade.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)